Bank Of America Corp Acadia Pharmaceuticals Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 695,518 shares of ACAD stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

695,518

Previous 248,620 179.75%

Holding current value

$10.3 Million

Previous $4.6 Million 145.91%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $6.53 Million - $8.23 Million	446,898 Added 179.75%	695,518 $11.3 Million
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $4.61 Million - $7.99 Million	-259,067 Reduced 51.03%	248,620 $4.6 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $6.21 Million - $9.49 Million	-298,795 Reduced 37.05%	507,687 $15.9 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $2.58 Million - $3.72 Million	144,843 Added 21.89%	806,482 $19.3 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $1.05 Million - $1.35 Million	-64,486 Reduced 8.88%	661,639 $12.5 Million
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $3.43 Million - $4.5 Million	241,794 Added 49.92%	726,125 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $1.32 Million - $1.71 Million	93,538 Added 23.94%	484,331 $7.92 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $1.43 Million - $2.98 Million	-109,580 Reduced 21.9%	390,793 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $4.11 Million - $5.4 Million	196,202 Added 64.5%	500,373 $12.1 Million
Q4 2021 Feb 08, 2022	BUY	$16.79 - $27.09 $221,846 - $357,940	13,213 Added 4.54%	304,171 $7.1 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $3.12 Million - $4.89 Million	-197,589 Reduced 40.44%	290,958 $4.83 Million
Q2 2021 Sep 13, 2021	BUY	$19.4 - $27.42 $9.48 Million - $13.4 Million	488,547 New	488,547 $11.9 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Acadia Pharmaceuticals Inc Transaction History